Advertisement
Acorda Withdraws Proposal To Raise Authorized Shares From Special Meeting Of Stockholders
(RTTNews) - Acorda Therapeutics, Inc. (ACOR) announced Monday that it has withdrawn Proposal One, a request to increase the number of authorized shares of Acorda stock, from the ballot for the Special Meeting of Stockholders scheduled for November 4, 2022.
Proposal Two, authorization of a Reverse Stock Split, remains on the ballot. This proposal would give Acorda's Board of Directors the ability to implement a reverse stock split of Acorda's stock. The will ensure that the company's stock price moves above $1.00, which would prevent the company from being delisted by Nasdaq.
Proposal Three, the Adjournment Proposal, to allow the Company to adjourn and reconvene the Special Meeting to have additional time to solicit proxies, will also remain on the ballot.
Acorda Therapeutics COO Lauren Sabella To Resign
European Shares Rally As Trade Tensions Ease
Asian Shares Rally As Sino-US Trade Tensions Ease
Apple Shares Down On $900 Mln Tariff Hit, Despite Strong Q2, Dividend Growth, $100 Bln Buyback
Australian Dollar Rises Against Majors
Yen Slides Against Majors
European Shares To Open Higher On US-China Trade Talk Optimism
